Current perspectives on wearable rhythm recordings for clinical decision-making: the wEHRAbles 2 survey

Author:

Manninger Martin1,Zweiker David12,Svennberg Emma3,Chatzikyriakou Sofia4,Pavlovic Nikola5ORCID,Zaman Junaid A.B.67,Kircanski Bratislav8,Lenarczyk Radoslaw9,Vanduynhoven Philippe10,Kosiuk Jedrzej11,Potpara Tatjana1213,Duncker David14ORCID

Affiliation:

1. Division of Cardiology, Department of Medicine, Medical University of Graz, Graz, Austria

2. 3rd Medical Department for Cardiology and Intensive Care, Klinik Ottakring, Vienna, Austria

3. Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

4. Department of Cardiology, Clinic Saint-Jean, Brussels, Belgium

5. University Hospital Center Sestre Milosrdnice, Zagreb, Croatia

6. Royal Brompton Hospital, London, UK

7. University of Southern California, Los Angeles, CA, USA

8. Clinical Centre of Serbia, Pacemaker Centre, Belgrade, Serbia

9. Department of Cardiology, Congenital Heart Defects and Electrotherapy, Medical University of Silesia, Silesian Centre for Heart Disease, Zabrze, Poland

10. Department of Cardiology, Arrhythmia Clinic, ASZ Aalst, Aalst, Belgium

11. Helios Clinic Koethen, Koethen, Germany

12. Faculty of Medicine, University of Belgrade, Belgrade, Serbia

13. Department for Intensive Care in Cardiac Arrhythmias, Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia

14. Hannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany

Abstract

Abstract Novel wearable devices for heart rhythm analysis using either photoplethysmography (PPG) or electrocardiogram (ECG) are in daily clinical practice. This survey aimed to assess impact of these technologies on physicians’ clinical decision-making and to define, how data from these devices should be presented and integrated into clinical practice. The online survey included 22 questions, focusing on the diagnosis of atrial fibrillation (AF) based on wearable rhythm device recordings, suitable indications for wearable rhythm devices, data presentation and processing, reimbursement, and future perspectives. A total of 539 respondents {median age 38 [interquartile range (IQR) 34–46] years, 29% female} from 51 countries world-wide completed the survey. Whilst most respondents would diagnose AF (83%), fewer would initiate oral anticoagulation therapy based on a single-lead ECG tracing. Significantly fewer still (27%) would make the diagnosis based on PPG-based tracing. Wearable ECG technology is acceptable for the majority of respondents for screening, diagnostics, monitoring, and follow-up of arrhythmia patients, while respondents were more reluctant to use PPG technology for these indications. Most respondents (74%) would advocate systematic screening for AF using wearable rhythm devices, starting at patients’ median age of 60 (IQR 50–65) years. Thirty-six percent of respondents stated that there is no reimbursement for diagnostics involving wearable rhythm devices in their countries. Most respondents (56.4%) believe that costs of wearable rhythm devices should be shared between patients and insurances. Wearable single- or multiple-lead ECG technology is accepted for multiple indications in current clinical practice and triggers AF diagnosis and treatment. The unmet needs that call for action are reimbursement plans and integration of wearable rhythm device data into patient’s files and hospital information systems.

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3